Skip to content

Dual Hemisphere rTMS for Rehabilitation of Post Stroke Aphasia

Treatment of Aphasic Stroke Patients With rTMS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01850836
Enrollment
29
Registered
2013-05-10
Start date
2010-12-31
Completion date
2013-01-31
Last updated
2013-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Fluent Aphasia in Subacute Stroke

Keywords

Aphasia, Stroke, repetitive transcranial magnetic stimulation.

Brief summary

To investigate the therapeutic effect of dual hemisphere repetitive transcranial magnetic stimulation (rTMS) on post-stroke non fluent aphasia.

Detailed description

Thirty patients with subacute post-stroke non-fluent aphasia were randomly allocated with a ratio 2:1 to receive real (n = 20) or sham (n = 10) rTMS of the affected motor cortex. Each patient received 1000 rTMS pulses (1 Hertz at 110% of resting motor threshold) over the unaffected Broca's area and 1000 pulses (20 Hertz at 100% resting motor threshold) over affected left Broca's area for 10 consecutive days. LANGUAGE section of hemispheric stroke scale, Stroke Aphasic Depression Questionnaire Hospital Version (SADQ-H) and NIH stroke scale were assessed before, post sessions, 1 and 2 months after the last session . Motor threshold was assessed before and after the end of last session.

Interventions

PROCEDURErepetitive transcranial magnetic stimulation

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* acute hemiplegia with non-fluent aphasia, single thromboembolic non-haemorrhagic infarction documented by computerized tomography (CT) in the distribution of middle cerebral artery.

Exclusion criteria

* head injury or neurological disease other than stroke, * Unstable cardiac dysrhythmia, * Fever, * Infection, * Hyperglycaemia * Prior administration of tranquilizer * Patients with no motor evoked response recorded from first dorsal interosseus (FDI) muscle of the affected hand

Design outcomes

Primary

MeasureTime frameDescription
Hemispheric stroke scale (HSS)Change from Baseline in HSS at 2 monthsLanguage assessment using hemispheric stroke scale (HSS)

Secondary

MeasureTime frame
NIH Stroke Scale (NIHSS)Change from Baseline in NIHSS at 2 months

Other

MeasureTime frameDescription
Stroke Aphasic Depression Questionnaire Hospital Version (SADQ-H)Change from Baseline in SADQ-H at 2 months(Asking about presence of depressive symptoms within last week of stroke to be present all the days or frequent from 4-6 days, or infrequent from 1-4 days, or not at all).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026